loading
Precedente Chiudi:
$3.47
Aprire:
$3.53
Volume 24 ore:
376.09K
Relative Volume:
0.49
Capitalizzazione di mercato:
$642.57M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-7.625
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
+2.29%
1M Prestazione:
+6.85%
6M Prestazione:
-2.19%
1 anno Prestazione:
-4.42%
Intervallo 1D:
Value
$3.305
$3.54
Intervallo di 1 settimana:
Value
$3.26
$3.55
Portata 52W:
Value
$2.705
$4.725

Arbutus Biopharma Corp Stock (ABUS) Company Profile

Name
Nome
Arbutus Biopharma Corp
Name
Telefono
604-419-3200
Name
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Name
Dipendente
44
Name
Cinguettio
@arbutusbio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
ABUS's Discussions on Twitter

Confronta ABUS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ABUS
Arbutus Biopharma Corp
3.355 653.11M 12.99M -74.39M -78.92M -0.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
377.71 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.66 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
430.63 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
668.20 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.01 33.25B 3.81B -644.79M -669.77M -6.24

Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-02-02 Aggiornamento Jefferies Hold → Buy
2021-02-25 Iniziato Jefferies Hold
2020-12-17 Iniziato H.C. Wainwright Buy
2020-07-27 Ripresa JMP Securities Mkt Outperform
2020-07-24 Downgrade Robert W. Baird Outperform → Neutral
2020-05-19 Aggiornamento Wedbush Neutral → Outperform
2020-03-06 Aggiornamento Chardan Capital Markets Neutral → Buy
2020-02-20 Iniziato Robert W. Baird Outperform
2020-02-05 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2019-10-07 Reiterato B. Riley FBR Buy
2019-10-04 Downgrade Chardan Capital Markets Buy → Neutral
2018-10-16 Aggiornamento B. Riley FBR Neutral → Buy
2018-10-15 Aggiornamento Wedbush Underperform → Neutral
2018-10-12 Reiterato Chardan Capital Markets Buy
2018-07-06 Downgrade B. Riley FBR, Inc. Buy → Neutral
2018-03-19 Ripresa Chardan Capital Markets Buy
2018-03-19 Downgrade Wedbush Outperform → Neutral
2018-01-05 Iniziato B. Riley FBR, Inc. Buy
2017-04-04 Aggiornamento Chardan Capital Markets Neutral → Buy
2017-02-01 Reiterato Wedbush Outperform
2016-12-13 Downgrade Chardan Capital Markets Buy → Neutral
2016-11-30 Aggiornamento Chardan Capital Markets Neutral → Buy
Mostra tutto

Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie

pulisher
02:33 AM

What risks could impact Arbutus Biopharma Corporation stock performanceLong Term Stock Growth Plan Suggestions - Newser

02:33 AM
pulisher
Aug 06, 2025

Arbutus Biopharma Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com South Africa

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Biopharma Reports Q2 Earnings of $2.523mln, Revenue of $10.739mln, EPS of $0.01 - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus: Q2 Earnings Snapshot - WFMJ.com

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Biopharma Corp Reports Q2 2025 Earnings: EPS of $0.01 an - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

Aug 06, 2025
pulisher
Aug 06, 2025

Real time social sentiment graph for Arbutus Biopharma CorporationHigh Return Strategy with Low Risk - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Arbutus Biopharma (ABUS) Projected to Post Earnings on Thursday - Defense World

Aug 06, 2025
pulisher
Aug 06, 2025

Forecasting Arbutus Biopharma Corporation price range with options dataTriple Digit Gain Opportunity Watchlist - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Is Arbutus Biopharma Corporation stock reversal real or fakeAI Trend Detection for Entry Timing - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Arbutus Biopharma Corporation stock trendline breakdownMarket Timing Strategy with Technical Filters - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Applying big data sentiment scoring on Arbutus Biopharma CorporationWeekly Price Target Forecast and Alerts - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

When is the best time to buy Arbutus Biopharma Corporation stockSafe Entry Strategy with High Win Rate - Newser

Aug 03, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for Arbutus Biopharma CorporationBuild a diversified portfolio for steady growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Arbutus Biopharma CorporationTriple-digit returns - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What data driven models say about Arbutus Biopharma Corporation’s futureShort Term High Yield Stock Tips for Active Traders - beatles.ru

Aug 02, 2025
pulisher
Aug 01, 2025

Bank of New York Mellon Corp Decreases Holdings in Arbutus Biopharma Corporation (NASDAQ:ABUS) - Defense World

Aug 01, 2025
pulisher
Jul 31, 2025

Why Arbutus Biopharma Corporation stock attracts strong analyst attentionFree AI Trading Suggestions With Accuracy Focus - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Is now a turning point for Arbutus Biopharma CorporationWeekly Portfolio Update with ROI Focus - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Technical analysis overview for Arbutus Biopharma Corporation stockFree Buy Low Sell High Stock Watch - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Arbutus Biopharma Corporation Recovery Hinges on Volume BreakoutSecure Return Focused Investment Plan Released - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 00:59:28 - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Will breakout in Arbutus Biopharma Corporation lead to full recoveryFree Reliable Chart-Based Trade Entries - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:59:46 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Arbutus Biopharma Corporation stock higher in 2025Consistently exceptional gains - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Arbutus Biopharma Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView

Jul 28, 2025
pulisher
Jul 28, 2025

Does Arbutus Biopharma Corporation stock perform well during market downturnsRapid market gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Arbutus Biopharma Corporation stock expected to show significant growthConsistent triple returns - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Arbutus Biopharma Corporation company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Arbutus Biopharma Corporation stockDiscover stocks with massive upside potential - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 03:47:36 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Arbutus Biopharma Corporation Stock a Smart Buy in 2025 Investment Analysis InsideVerified Return Tips - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Arbutus Biopharma Corporation stock performs during market volatilityFree Stock Investment Growth Plan - Newser

Jul 27, 2025
pulisher
Jul 24, 2025

Is Arbutus Biopharma Corporation a good long term investmentMassive wealth growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Arbutus Biopharma Corporation stockSuperior returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Arbutus Biopharma Corporation (NASDAQ:ABUS) Position Cut by Teacher Retirement System of Texas - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

What drives Arbutus Biopharma Corporation stock priceSuperior stock growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Arbutus Biopharma Corporation Stock Analysis and ForecastDynamic profit opportunities - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

What makes Arbutus Biopharma Corporation stock price move sharplyFree Deep Market Trend Analysis - Newser

Jul 15, 2025

Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.61
price down icon 0.14%
$37.02
price down icon 0.24%
$108.85
price down icon 2.07%
$27.82
price down icon 2.59%
$111.57
price up icon 0.27%
biotechnology ONC
$296.17
price down icon 0.94%
Capitalizzazione:     |  Volume (24 ore):